Global ADHD Medication Market Report, History and Forecast 2018-2034, Breakdown Data by Companies, Key Regions, Types and Application
Published on: 2024-01-04 | No of Pages : 400 | Industry : Pharma & Healthcare
Publisher : MRA | Format : PDF
Global ADHD Medication Market Report, History and Forecast 2018-2034, Breakdown Data by Companies, Key Regions, Types and Application
Stimulants are the best and most common type of medication used to treat ADHD.
ADHD Medication report published by QYResearch reveals that COVID-19 and Russia-Ukraine War impacted the market dually in 2022. Global ADHD Medication market is projected to reach US$ million in 2034, increasing from US$ million in 2022, with the CAGR of % during the period of 2024 to 2034. Demand from Attention Deficit and Hyperactivity/impulse Control Disorder are the major drivers for the industry.
Johnson & Johnson is the largest manufacturer of ADHD medication in China, has a market share of over 40%. Other key players include Eli Lilly and Zhengda Fenghai, etc. Geographically speaking, East China is the largest market, has a market share of about 25%. In terms of type, both stimulants and non-stimulants account for about 50% of market share. In terms of application, hybrid is the dominant field using ADHD medication, has a market share of over 80%.
Report Scope
This report, based on historical analysis (2018-2022) and forecast calculation (2024-2034), aims to help readers to get a comprehensive understanding of global ADHD Medication market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.
Companies, Type, Application and Regions Listed in the Report
Takeda
Johnson & Johnson
Novartis
Eli Lilly
Tris Pharma, Inc
Neos Therapeutics
Mallinckrodt
Amneal Pharmaceuticals
Noven Pharmaceuticals
Purdue Parma
Zhengda Fenghai
Segment by Type
Stimulant
Non-stimulant
Attention Deficit
Hyperactivity/impulse Control Disorder
Hybrid
By Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Latin America
Mexico
Brazil
Middle East & Africa
Turkey
Saudi Arabia
UAE
Each chapter of the report provides detailed information for readers to understand the ADHD Medication market further
Chapter 1Global and regional market size and CAGR for the history and forecast period (2018-2024, 2024-2034).
Chapter 2Product Types and Revenue analysis of Each Type in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2018 to 2024.
Chapter 3Product Application and Revenue analysis of Each Application in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2018 to 2024.
Chapter 4Company Competition Status, Detailed analysis of Product Name companies’ competitive landscape, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter 5Companies’ Outline, covering company’s basic information, ADHD Medication introduction, etc. ADHD Medication Revenue and Gross Margin of each company as well as Recent Development are also contained in this part.
Chapter 6 to 10Country Level analysis of North America, Europe, Asia-Pacific, Latin America, Middle East and Africa by revenue.
Chapter 11Market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry.
Chapter 12QYResearch’s Conclusions of ADHD Medication market based on comprehensive survey.
Chapter 13Methodology and Data Sources adopted by QYResearch.
ADHD Medication report published by QYResearch reveals that COVID-19 and Russia-Ukraine War impacted the market dually in 2022. Global ADHD Medication market is projected to reach US$ million in 2034, increasing from US$ million in 2022, with the CAGR of % during the period of 2024 to 2034. Demand from Attention Deficit and Hyperactivity/impulse Control Disorder are the major drivers for the industry.
Johnson & Johnson is the largest manufacturer of ADHD medication in China, has a market share of over 40%. Other key players include Eli Lilly and Zhengda Fenghai, etc. Geographically speaking, East China is the largest market, has a market share of about 25%. In terms of type, both stimulants and non-stimulants account for about 50% of market share. In terms of application, hybrid is the dominant field using ADHD medication, has a market share of over 80%.
Report Scope
This report, based on historical analysis (2018-2022) and forecast calculation (2024-2034), aims to help readers to get a comprehensive understanding of global ADHD Medication market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.
Companies, Type, Application and Regions Listed in the Report
By Company
Takeda
Johnson & Johnson
Novartis
Eli Lilly
Tris Pharma, Inc
Neos Therapeutics
Mallinckrodt
Amneal Pharmaceuticals
Noven Pharmaceuticals
Purdue Parma
Zhengda Fenghai
Segment by Type
Stimulant
Non-stimulant
Segment by Application
Attention Deficit
Hyperactivity/impulse Control Disorder
Hybrid
By Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Latin America
Mexico
Brazil
Middle East & Africa
Turkey
Saudi Arabia
UAE
Each chapter of the report provides detailed information for readers to understand the ADHD Medication market further
Chapter 1Global and regional market size and CAGR for the history and forecast period (2018-2024, 2024-2034).
Chapter 2Product Types and Revenue analysis of Each Type in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2018 to 2024.
Chapter 3Product Application and Revenue analysis of Each Application in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2018 to 2024.
Chapter 4Company Competition Status, Detailed analysis of Product Name companies’ competitive landscape, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter 5Companies’ Outline, covering company’s basic information, ADHD Medication introduction, etc. ADHD Medication Revenue and Gross Margin of each company as well as Recent Development are also contained in this part.
Chapter 6 to 10Country Level analysis of North America, Europe, Asia-Pacific, Latin America, Middle East and Africa by revenue.
Chapter 11Market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry.
Chapter 12QYResearch’s Conclusions of ADHD Medication market based on comprehensive survey.
Chapter 13Methodology and Data Sources adopted by QYResearch.
Electronic and Semiconductor
Food and Beverages
Chemicals and Materials
Consumer Goods
Construction Manufacturing
Aerospace and Defence
Energy and Power
ICT Media
Banking and Finance
Automotive and Transportation
Machinery and Equipments
Pharmaceutical and Healthcare
Medical Devices